Foppiano, F.* ; Böck, A.* ; Beerweiler, C.* ; Urner, K.* ; Ege, M.* ; Schmaußer-Hechfellner, E. ; Skevaki, C.* ; Frey, U.* ; Riedler, J.* ; Frei, R.* ; Lauener, R.* ; Roduit, C.* ; Karvonen, A.M.* ; Roponen, M.* ; Pekkanen, J.* ; Divaret-Chauveau, A.* ; Barnig, C.* ; von Mutius, E. ; Schaub, B.*
Early neutrophil and persistent eosinophil-associated gene signature in childhood asthma.
Am. J. Respir. Crit. Care Med. 212, 1214-1226 (2026)
RationaleEarly
childhood represents a critical window for asthma susceptibility,
marked by developmental and molecular changes, yet their longitudinal
pattern remains unclear.ObjectivesTo
identify differences in longitudinal whole-blood gene expression during
early childhood in future asthmatics compared to healthy children.MethodsWe
conducted a longitudinal whole-blood transcriptomic analysis at four
timepoints (1, 4.5, 6, 10.5 years) in a sample of the birth cohort
PASTURE (n = 378), comparing children who developed asthma between 6 and
10.5 years with non-asthmatic controls (83/295). Analyses included
longitudinal differential gene expression, weighted gene co-expression
network analysis, and cis-eQTL analysis.Measurements and main resultsAt
age 1, 42 genes, mostly upregulated in future asthmatics, were
associated with neutrophilic inflammation and NLRP3
inflammasome-markers. By 4.5 years, this shifted to a novel
eosinophil-related signature (40 genes), remaining increased in
asthmatics until 10.5 years. Co-expression analysis confirmed a
neutrophilic module at 1 year and eosinophilic modules at 4.5, 6 and
10.5 years, all associated with asthma. Fractional exhaled nitric oxide
was associated with the eosinophilic module at age 6 (P = .003).
86 SNPs were identified modulating the expression of 10
eosinophil-associated genes and GSDMB from this eosinophilic signature. A
variant-based genetic risk score was associated with asthma diagnosis
(aOR[95% CI]= 1.47[1.13-1.93]).ConclusionWe
identified a shift from a neutrophil-driven gene signature at age 1 to a
persistent eosinophilic signature at 4.5 to 10.5 years in asthmatic
children, highlighting the 1 to 4.5-year period as most vulnerable
period. Genetic variants strongly influenced the persistent eosinophilic
gene signature, comprising potential novel therapeutic targets.
Altmetric
Additional Metrics?
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Asthma ; Exhaled Nitric Oxide ; Longitudinal Study ; Snp ; Gene Signature ; Cohort ; Eosinophilic ; Gene ; Single-nucleotide Polymorphism; Wheeze; Inflammation; Exposure
Keywords plus
ISSN (print) / ISBN
1073-449X
e-ISSN
1535-4970
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 212,
Issue: 6,
Pages: 1214-1226
Article Number: ,
Supplement: ,
Series
Publisher
American Thoracic Society
Publishing Place
Great Clarendon St, Oxford Ox2 6dp, England
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Asthma and Allergy Prevention (IAP)
Environmental Health Center (EHC)
Grants
Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding
Khne Foundation-Research
Finnish Institute for Health and Welfare
DFG
German Center for Child and Adolescent Health
Bundesministerium fr Bildung und Forschung
Pivikki and Sakari Sohlberg Foundation
German Center of Lung Research
Juho Vainio Foundation
Federal Ministry of Education and Research
Foundation for Pediatric Research
Yrj Jahnsson Foundation
Farmers' Social Insurance Institution of Finland
Academy of Finland
BMBF
Finnish Cultural Foundation
Copyright